StreetAlpha
13F holdings · Q3 2026

ADAR1 Capital Management

Austin, TX · files as ADAR1 Capital Management, LLC
Know the moment ADAR1 Capital Management filesYou follow ADAR1 Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1940272

ADAR1 Capital Management reported 262 stocks worth $2.3B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ABVX (8.8%), SPY (5.9%) and PTGX (5.8%). Compared with Q2 2026, the fund opened new positions in FRNM, ABCL and VOGX, added to ABVX, SPY and ZLAB, trimmed PTGX, ROIV and IMVT and sold out of FTH, FRNM and BHF.

Latest filing: what ADAR1 Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HR/AView on SEC ↗
41 new84 added60 trimmed41 sold outBought about $513M · sold about $186M
New 41
See all 41 →
Added 84
See all 84 →
Trimmed 60
See all 60 →
Sold out 41
  • Crinetics Pharmace$45.7M
  • Teva Pharmaceutica$9.4M
  • FTH$9M
  • FRNM$7.3M
  • Galecto Inc$7.3M
See all 41 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$2.3B+9.5% vs last quarter
Stocks held26241 new · 41 sold out
Top 5 weight29.1%spread out
Turnover36%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
ABVX
Abivax SA
$203M8.8%2.1M+246K (+14%)8 of 8
2
SPY
Spdr S&P 500 ETF TR
$135M5.9%178K+49K (+38%)6 of 8
3
PTGX
Protagonist Therapeutics Inc
$134M5.8%951K−9,460 (−1%)8 of 8
4
ROIV
Roivant Sciences Ltd
$113M4.9%3.1M−77K (−2%)8 of 8
5
ZLAB
Zai Lab Ltd
$89.1M3.9%3.4M+12K (+0%)8 of 8
6
IMVT
Immunovant Inc
$71.5M3.1%2.1M−215K (−9%)8 of 8
7
XENE
Xenon Pharmaceuticals Inc
$43.2M1.9%1.2M+995K (+598%)8 of 8
8
DNLI
Denali Therapeutics Inc
$42.8M1.9%2.1M+1M (+101%)8 of 8
9
BOXX
EA Series Trust
$39.9M1.7%337KNo change8 of 8
10
SEPN
Septerna Inc
$38.1M1.6%974K+34K (+4%)7 of 8
🔒 252 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
CRINETICS PHARMACEUTICALS IN
$45.7M1.2M
TEVA PHARMACEUTICAL INDS LTD
$9.4M278K
FTH
Sensei Biotherapeutics Inc
$9M361K
FRNM
Perceptive Cap Solutions Cor
$7.3M675K
GALECTO INC
$7.3M280K

🔒 Free account: see all 30.

Options

valued at the underlying shares
StockTypeValueSharesChange
PRAX
Praxis Precision Medicines I
Call$8.7M30K+30,000
ABVX
Abivax SA
Call$6.9M70K+25,600
IOVA
Iovance Biotherapeutics Inc
Put$741K50K+50,000
RARE
Ultragenyx Pharmaceutical in
Call$301K20K0

Reported value

last 8 quarters
$469MQ4 '24
$505MQ1 '25
$609MQ2 '25
$1BQ3 '25
$1.3BQ4 '25
$1.7BQ1 '26
$2.1BQ2 '26
$2.3BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HR/A AmendmentQ3 2026SEC filing ↗
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Includes an amendment, which can add positions the fund kept confidential at first, or replace the original report.

Other superinvestors

All hedge fund holdings →

ADAR1 Capital Management 13F FAQ

What does ADAR1 Capital Management own?

ADAR1 Capital Management reported 262 stocks worth $2.3B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ABVX (8.8%), SPY (5.9%) and PTGX (5.8%). The table above lists every position in the filing (the top 10 without an account).

What did ADAR1 Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 41 new positions, 84 added to, 60 trimmed and 41 sold out. New positions include FRNM, ABCL and VOGX. It sold all of FTH, FRNM and BHF.

When will ADAR1 Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is ADAR1 Capital Management's portfolio worth?

The Q3 2026 filing reports $2.3B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.